Inactive Instrument

Sartorius Stedim Biotech SA Stock Euronext Paris

Equities

STDM

FR0000053266

Medical Equipment, Supplies & Distribution

End-of-day quote Euronext Paris
- EUR - Intraday chart for Sartorius Stedim Biotech SA
Sales 2024 * 2.99B 3.17B Sales 2025 * 3.44B 3.65B Capitalization 24.78B 26.3B
Net income 2024 * 359M 381M Net income 2025 * 497M 528M EV / Sales 2024 * 9.27 x
Net Debt 2024 * 2.9B 3.08B Net Debt 2025 * 2.65B 2.81B EV / Sales 2025 * 7.97 x
P/E ratio 2024 *
64.7 x
P/E ratio 2025 *
46.6 x
Employees -
Yield 2024 *
0.31%
Yield 2025 *
0.4%
Free-Float 31.97%
More Fundamentals * Assessed data

Latest transcript on Sartorius Stedim Biotech SA

Managers TitleAgeSince
Chief Executive Officer 48 19-03-25
Chairman 59 07-06-28
Chief Tech/Sci/R&D Officer 59 09-04-28
Members of the board TitleAgeSince
Director/Board Member 62 07-06-28
Chairman 59 07-06-28
Director/Board Member 67 15-04-06
More insiders
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Calendar
More about the company